Bayer To Allocate 10 Million Yuan For Community Health In China
This article was originally published in PharmAsia News
Bayer HealthCare has announced that, starting this month, it will allocate 10 million yuan ($1.45 billion) for China's community health establishment project, the largest ever between a non-government organization and the Ministry of Health. MOH officials say the project will actively publicize community health services in the next three years, including training administrators, developing and extending suitable practice standards, as well as supporting community health organizations to conduct health education and promotion. Besides Bayer, Johnson & Johnson, Pfizer and Novartis have also participated in such exercises. Industry observers point out that the strategy builds up a favorable image of corporate responsibility on social welfare. The perception will help companies concerned project a reliable reputation, benefiting their bids for drug tenders and their drugs' inclusion in the medicine catalog. (Click here for more - Chinese Language
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.